Study assesses the rate of rare blood clots in adults receiving Oxford-AstraZeneca vaccine by rss feed | May 7, 2021 | News Feeds A large study from Denmark and Norway published by The BMJ today sheds more light on the risk of rare blood clots in adults receiving their first dose of the Oxford-AstraZeneca covid-19 vaccine. Read Original Copy